Back to Trades
Grant4
QUEST DIAGNOSTICS INC
DGX
Total Value
$1.6M
Company Information
- Company Name
- QUEST DIAGNOSTICS INC
- Ticker Symbol
- DGX
- CIK
- 0001022079
Insider Information
- Name
- DELANEY MARK E
- Role
- SVP & Chief Commercial Officer
- Location
- SECAUCUS, NJ
Officer
Filing Details
- Filing Date
- Feb 20, 2026
- Transaction Date
- Feb 18, 2026
- Accession Number
- 0001955265-26-000002
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 18, 2026 | Common Stock | 1,586 | — | Grant/Award | — |
| Feb 18, 2026 | Common Stock | 205 | $210.01 | Tax Withholding | $43.1K |
| Feb 18, 2026 | Common Stock | 230 | $206.99 | Tax Withholding | $47.6K |
| Jan 28, 2026 | Common Stock | 15 | $183.51 | Small Acquisition | $2.8K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Feb 18, 2026 | Derivative | 7,332 | $204.96 | Grant/Award | $1.5M |
Footnotes
- (F1)Represents an award of restricted stock units.
- (F2)Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.
- (F3)Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.
- (F4)The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.